Skip to main content
Top
Published in: Nutrition & Metabolism 1/2016

Open Access 01-12-2016 | Research

Effects of controlled doses of Oxyelite Pro on physical performance in rats

Authors: Paulo Vinicios Camuzi Zovico, Victor Magalhães Curty, Marcos André Soares Leal, Eduardo Frizzera Meira, Daniel Ventura Dias, Lívia Carla de Melo Rodrigues, Silvana dos Santos Meyrelles, Edilamar Menezes De Oliveira, Paula Frizera Vassallo, Valério Garrone Barauna

Published in: Nutrition & Metabolism | Issue 1/2016

Login to get access

Abstract

Background

OxyElite Pro (OEP) is a dietary supplement to increase metabolism which contains as key stimulant the ingredient 1,3-dimethylamylamine (DMAA). Serious adverse effects have been reported after OEP consumption however, these effects are related to poisoning or overdose. To our knowledge, no one studied the effects of OEP at controlled doses. Thus, the aim of this study was to evaluate acute and chronic OEP affects, at controlled doses in Wistar rats, on physical performance, metabolic parameters, liver injury markers and oxidative stress markers and mitochondrial biogenesis in skeletal muscle.

Methods

Rats were divided in control, 4.3 mg OEP/kg, 12.9 mg OEP/kg and 25.8 mg OEP/kg. All groups were submitted to supplementation with OEP for 4 weeks and the experimental protocols were performed 30 min after the first OEP administration (acute response) and 30 min after the last OEP administration at the end of the forth week (chronic response).

Results

Running distance and running time increased after acute administration of 12.9 mg OEP/kg (2.6-fold) and 25.8 mg OEP/kg (2.8-fold). Since no effect on the exercise tolerance test was observed at the lower OEP dose (4.3 mg OEP/kg), this group was removed from further analyzes. On other hand, running distance and running time decreased after daily supplementation for 4 weeks also in both groups (64% in 12.9 mg OEP/kg and 72% in 25.8 mg OEP/kg). Chronic supplementation at both 12.9 and 25.8 mg OEP/kg decreased TBARS levels in soleus muscle (36 and 31%) and liver (43 and 25%). AOPP was also decreased by both doses in the liver (39 and 45%). Chronic administration of the highest dose, 25.8 mg OEP/kg, was able to reduce mRNA expression of PGC-1α in soleus muscle (25%). No effect was found in other analyses such as spontaneous physical activity, body weight, food and water intake, hepatic toxicity, cardiac oxidative stress and mitochondrial DNA amount.

Conclusion

Maximum and not recommended doses of OEP ingested acutely presented stimulating effect on the ability to exercise. However, its daily consumption for 4 weeks showed antioxidant effects in soleus muscle and liver which may have decreased the PGC-1α mRNA expression on soleus muscle and contributed to the impaired performance in the exercise tolerance test.
Literature
1.
go back to reference McCarthy CG, Farney TM, Canale RE, Alleman RJ. A Finished Dietary Supplement Stimulates Lipolysis and Metabolic Rate in Young Men and Women. Nutr Metab Insights. 2011;5:23–31.PubMedPubMedCentral McCarthy CG, Farney TM, Canale RE, Alleman RJ. A Finished Dietary Supplement Stimulates Lipolysis and Metabolic Rate in Young Men and Women. Nutr Metab Insights. 2011;5:23–31.PubMedPubMedCentral
2.
go back to reference Geller AI, Shehab N, Weidle NJ, Lovegrove MC, Wolpert BJ, Timbo BB, et al. Emergency Department Visits for Adverse Events Related to Dietary Supplements. N Engl J Med. 2015;373:1531–40.CrossRefPubMed Geller AI, Shehab N, Weidle NJ, Lovegrove MC, Wolpert BJ, Timbo BB, et al. Emergency Department Visits for Adverse Events Related to Dietary Supplements. N Engl J Med. 2015;373:1531–40.CrossRefPubMed
3.
go back to reference McCarthy CG, Canale RE, Alleman RJ, Reed JP, Bloomer RJ, McCarthy CG, et al. Biochemical and Anthropometric Effects of a Weight Loss Dietary Supplement in Healthy Men and Women. Nutr Metab Insights. 2012;5:13–22.PubMed McCarthy CG, Canale RE, Alleman RJ, Reed JP, Bloomer RJ, McCarthy CG, et al. Biochemical and Anthropometric Effects of a Weight Loss Dietary Supplement in Healthy Men and Women. Nutr Metab Insights. 2012;5:13–22.PubMed
4.
go back to reference Roytman MM, Pörzgen P, Lee CL, Huddleston L, Kuo TT, Bryant-Greenwood P, et al. Outbreak of Severe Hepatitis Linked to Weight-Loss Supplement OxyELITE Pro. Am J Gastroenterol. 2014;109:1296–8.CrossRefPubMed Roytman MM, Pörzgen P, Lee CL, Huddleston L, Kuo TT, Bryant-Greenwood P, et al. Outbreak of Severe Hepatitis Linked to Weight-Loss Supplement OxyELITE Pro. Am J Gastroenterol. 2014;109:1296–8.CrossRefPubMed
5.
go back to reference Johnston DI, Chang A, Viray M, Chatham-Stephens K, He H, Taylor E, et al. Hepatotoxicity associated with the dietary supplement OxyELITE ProTM - Hawaii, 2013. Drug Test Anal. 2016;8:319–27.CrossRefPubMed Johnston DI, Chang A, Viray M, Chatham-Stephens K, He H, Taylor E, et al. Hepatotoxicity associated with the dietary supplement OxyELITE ProTM - Hawaii, 2013. Drug Test Anal. 2016;8:319–27.CrossRefPubMed
6.
go back to reference Vaughan R, Garcia-Smith R, Barberena M, Bisoffi M, Trujillo K, Conn C. Treatment of human muscle cells with popular dietary supplements increase mitochondrial function and metabolic rate. Nutr Metab (Lond). 2012;9:101.CrossRef Vaughan R, Garcia-Smith R, Barberena M, Bisoffi M, Trujillo K, Conn C. Treatment of human muscle cells with popular dietary supplements increase mitochondrial function and metabolic rate. Nutr Metab (Lond). 2012;9:101.CrossRef
7.
go back to reference Vorce SP, Holler JM, Cawrse BM, Magluilo J. Dimethylamylamine: a drug causing positive immunoassay results for amphetamines. J Anal Toxicol. 2011;35:183–7.CrossRefPubMed Vorce SP, Holler JM, Cawrse BM, Magluilo J. Dimethylamylamine: a drug causing positive immunoassay results for amphetamines. J Anal Toxicol. 2011;35:183–7.CrossRefPubMed
8.
go back to reference Bloomer RJ, Farney TM, Harvey IC, Alleman RJ. Safety profile of caffeine and 1,3-dimethylamylamine supplementation in healthy men. Hum Exp Toxicol. 2013;32:1126–36.CrossRefPubMed Bloomer RJ, Farney TM, Harvey IC, Alleman RJ. Safety profile of caffeine and 1,3-dimethylamylamine supplementation in healthy men. Hum Exp Toxicol. 2013;32:1126–36.CrossRefPubMed
9.
go back to reference Venhuis BJ, De Kaste D. Scientific opinion on the regulatory status of 1, 3-dimethylamylamine (DMAA). Eur J Food Res Rev. 2012;2:93–100. Venhuis BJ, De Kaste D. Scientific opinion on the regulatory status of 1, 3-dimethylamylamine (DMAA). Eur J Food Res Rev. 2012;2:93–100.
10.
go back to reference Dolan SB, Gatch MB. Abuse liability of the dietary supplement dimethylamylamine. Drug Alcohol Depend Elsevier Ireland Ltd. 2015;146:97–102.CrossRef Dolan SB, Gatch MB. Abuse liability of the dietary supplement dimethylamylamine. Drug Alcohol Depend Elsevier Ireland Ltd. 2015;146:97–102.CrossRef
11.
go back to reference Fleming HL, Ranaivo PL, Simone PS. Analysis and confirmation of 1,3-DMAA and 1,4-DMAA in geranium plants using high performance liquid chromatography with tandem mass spectrometry at ng/g concentrations. Anal Chem Insights. 2012;7:59–78.PubMedPubMedCentral Fleming HL, Ranaivo PL, Simone PS. Analysis and confirmation of 1,3-DMAA and 1,4-DMAA in geranium plants using high performance liquid chromatography with tandem mass spectrometry at ng/g concentrations. Anal Chem Insights. 2012;7:59–78.PubMedPubMedCentral
12.
go back to reference Li JS, Chen M, Li ZC. Identification and quantification of dimethylamylamine in geranium by liquid chromatography tandem mass spectrometry. Anal Chem Insights. 2012;7:47–58.PubMedPubMedCentral Li JS, Chen M, Li ZC. Identification and quantification of dimethylamylamine in geranium by liquid chromatography tandem mass spectrometry. Anal Chem Insights. 2012;7:47–58.PubMedPubMedCentral
13.
go back to reference Zhang Y, Woods RM, Breitbach ZS, Armstrong DW. 1,3-dimethylamylamine (DMAA) in supplements and geranium products : natural or synthetic? Drug Test Anal. 2012;4:986–90.CrossRefPubMed Zhang Y, Woods RM, Breitbach ZS, Armstrong DW. 1,3-dimethylamylamine (DMAA) in supplements and geranium products : natural or synthetic? Drug Test Anal. 2012;4:986–90.CrossRefPubMed
14.
go back to reference Di Lorenzo C, Moro E, Dos Santos A, Uberti F, Restani P. Could 1,3 dimethylamylamine (DMAA) in food supplements have a natural origin? Drug Test Anal. 2013;5:116–21.CrossRefPubMed Di Lorenzo C, Moro E, Dos Santos A, Uberti F, Restani P. Could 1,3 dimethylamylamine (DMAA) in food supplements have a natural origin? Drug Test Anal. 2013;5:116–21.CrossRefPubMed
15.
go back to reference Archer JRH, Dargan PI, Lee HMD, Hudson S, Wood DM. Trend analysis of anonymised pooled urine from portable street urinals in central london identifies variation in the use of novel psychoactive substances. Clin Toxicol. 2014;52:160–5.CrossRef Archer JRH, Dargan PI, Lee HMD, Hudson S, Wood DM. Trend analysis of anonymised pooled urine from portable street urinals in central london identifies variation in the use of novel psychoactive substances. Clin Toxicol. 2014;52:160–5.CrossRef
16.
go back to reference Archer JRH, Dargan PI, Lostia AM, van der Walt J, Henderson K, Drake N, et al. Running an unknown risk: A marathon death associated with the use of 1,3-dimethylamylamine (DMAA). Drug Test Anal. 2015;7:433–8.CrossRefPubMed Archer JRH, Dargan PI, Lostia AM, van der Walt J, Henderson K, Drake N, et al. Running an unknown risk: A marathon death associated with the use of 1,3-dimethylamylamine (DMAA). Drug Test Anal. 2015;7:433–8.CrossRefPubMed
17.
go back to reference Whitehead PN, Schilling BK, Farney TM, Bloomer RJ. Impact of a Dietary Supplement Containing 1,3-Dimethylamylamine on Blood Pressure and Bloodborne Markers of Health: a 10-Week Intervention Study. Nutr Metab Insights. 2012;5:33–9.PubMedPubMedCentral Whitehead PN, Schilling BK, Farney TM, Bloomer RJ. Impact of a Dietary Supplement Containing 1,3-Dimethylamylamine on Blood Pressure and Bloodborne Markers of Health: a 10-Week Intervention Study. Nutr Metab Insights. 2012;5:33–9.PubMedPubMedCentral
18.
go back to reference Schilling BK, Hammond KG, Bloomer RJ, Presley CS, Yates CR. Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men. BMC Pharmacol Toxicol. 2013;14:52–61.CrossRefPubMedPubMedCentral Schilling BK, Hammond KG, Bloomer RJ, Presley CS, Yates CR. Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men. BMC Pharmacol Toxicol. 2013;14:52–61.CrossRefPubMedPubMedCentral
19.
go back to reference Rosic G, Joksimovic J, Selakovic D, Milovanovic D, Jakovljevic V. Anxiogenic effects of chronic exposure to nandrolone decanoate (ND) at supraphysiological dose in rats: A brief report. Neuroendocrinol Lett. 2014;35:703–10.PubMed Rosic G, Joksimovic J, Selakovic D, Milovanovic D, Jakovljevic V. Anxiogenic effects of chronic exposure to nandrolone decanoate (ND) at supraphysiological dose in rats: A brief report. Neuroendocrinol Lett. 2014;35:703–10.PubMed
20.
go back to reference Fernandes T, Nakamuta JS, Magalhães FC, Roque FR, Lavini-Ramos C, Schettert IT, et al. Exercise training restores the endothelial progenitor cells number and function in hypertension. J Hypertens. 2012;30:2133–43.CrossRefPubMed Fernandes T, Nakamuta JS, Magalhães FC, Roque FR, Lavini-Ramos C, Schettert IT, et al. Exercise training restores the endothelial progenitor cells number and function in hypertension. J Hypertens. 2012;30:2133–43.CrossRefPubMed
21.
go back to reference Berger RCM, Vassallo PF, De Oliveira CR, Oliveira ML, Martins FL, Nogueira BV, et al. Renal effects and underlying molecular mechanisms of long-term salt content diets in spontaneously hypertensive rats. PLoS ONE. 2015;10:1–17. Berger RCM, Vassallo PF, De Oliveira CR, Oliveira ML, Martins FL, Nogueira BV, et al. Renal effects and underlying molecular mechanisms of long-term salt content diets in spontaneously hypertensive rats. PLoS ONE. 2015;10:1–17.
22.
go back to reference Leal MA, Balarini CM, Dias AT, Porto ML, Gava AL, Pereira TMC, et al. Mechanisms of Enhanced Vasoconstriction in the Mouse Model of Athero- sclerosis : the Beneficial Effects of Sildenafil. Curr Pharm Biotechnol. 2015;16:517–30.CrossRefPubMed Leal MA, Balarini CM, Dias AT, Porto ML, Gava AL, Pereira TMC, et al. Mechanisms of Enhanced Vasoconstriction in the Mouse Model of Athero- sclerosis : the Beneficial Effects of Sildenafil. Curr Pharm Biotechnol. 2015;16:517–30.CrossRefPubMed
23.
go back to reference Foley S, Butlin E, Shields W, Lacey B. Experience with OxyELITE Pro and Acute Liver Injury in Active Duty Service Members. Dig Dis Sci. 2014;59:3117–21.CrossRefPubMed Foley S, Butlin E, Shields W, Lacey B. Experience with OxyELITE Pro and Acute Liver Injury in Active Duty Service Members. Dig Dis Sci. 2014;59:3117–21.CrossRefPubMed
24.
go back to reference Farney TM, Jr JA, Bloomer J. Hemodynamic and Hematologic Profile of Healthy Adults Ingesting Dietary supplements containing 1, 3-Dimethylamylamine and Caffeine. Nutr Metab Insights. 2012;5:1–12.PubMed Farney TM, Jr JA, Bloomer J. Hemodynamic and Hematologic Profile of Healthy Adults Ingesting Dietary supplements containing 1, 3-Dimethylamylamine and Caffeine. Nutr Metab Insights. 2012;5:1–12.PubMed
25.
go back to reference Bloomer RJ, Mccarthy CG, Farney TM, Harvey IC. Effect of Caffeine and 1,3-demethtlyamylamine on Exercise Performance and Blood Markers of Lipolysis and Oxidative Stress in Trained Men and Women. J Caffeine Res. 2011;1:169–77.CrossRef Bloomer RJ, Mccarthy CG, Farney TM, Harvey IC. Effect of Caffeine and 1,3-demethtlyamylamine on Exercise Performance and Blood Markers of Lipolysis and Oxidative Stress in Trained Men and Women. J Caffeine Res. 2011;1:169–77.CrossRef
26.
go back to reference Ryu S, Choi S, Joung S, Suh H, Cha Y, Lee S, et al. Caffeine as a Lipolytic Performance Food Component in Rats and Athletes. J Nutr Sci Vitaminol. 2001;47:139–46.CrossRefPubMed Ryu S, Choi S, Joung S, Suh H, Cha Y, Lee S, et al. Caffeine as a Lipolytic Performance Food Component in Rats and Athletes. J Nutr Sci Vitaminol. 2001;47:139–46.CrossRefPubMed
27.
go back to reference Spriet LL. Exercise and sport performance with low doses of caffeine. Sports Med. 2014;44 Suppl 2:S175–84.CrossRefPubMed Spriet LL. Exercise and sport performance with low doses of caffeine. Sports Med. 2014;44 Suppl 2:S175–84.CrossRefPubMed
28.
29.
go back to reference Gomez-Cabrera MC, Domenech E, Romagnoli M, Arduini A, Borras C, Pallardo FV, et al. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am J Clin Nutr. 2008;87:142–9.PubMed Gomez-Cabrera MC, Domenech E, Romagnoli M, Arduini A, Borras C, Pallardo FV, et al. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am J Clin Nutr. 2008;87:142–9.PubMed
30.
go back to reference Barcelos RP, Souza MA, Amaral GP, Stefanello ST, Bresciani G, Fighera MR, et al. Caffeine supplementation modulates oxidative stress markers in the liver of trained rats. Life Sci Elsevier Inc. 2014;96:40–5. Barcelos RP, Souza MA, Amaral GP, Stefanello ST, Bresciani G, Fighera MR, et al. Caffeine supplementation modulates oxidative stress markers in the liver of trained rats. Life Sci Elsevier Inc. 2014;96:40–5.
31.
go back to reference Ojuka EO, Jones TE, Han D, Chen MAY, Holloszy JO. Raising Ca 2 + in L6 myotubes mimics effects of exercise on mitochondrial biogenesis in muscle. FASEB J. 2003;17:675–81.CrossRefPubMed Ojuka EO, Jones TE, Han D, Chen MAY, Holloszy JO. Raising Ca 2 + in L6 myotubes mimics effects of exercise on mitochondrial biogenesis in muscle. FASEB J. 2003;17:675–81.CrossRefPubMed
32.
go back to reference Mcconell GK, Ng GPY, Phillips M, Ruan Z, Macaulay SL, Wadley GD. Central role of nitric oxide synthase in AICAR and caffeine-induced mitochondrial biogenesis in L6 myocytes. J Appl Physiol. 2010;108:589–95.CrossRefPubMed Mcconell GK, Ng GPY, Phillips M, Ruan Z, Macaulay SL, Wadley GD. Central role of nitric oxide synthase in AICAR and caffeine-induced mitochondrial biogenesis in L6 myocytes. J Appl Physiol. 2010;108:589–95.CrossRefPubMed
33.
go back to reference Vaughan RA, Garcia-smith R, Bisoffi M, Trujillo KA, Conn CA. Effects of Caffeine on Metabolism and Mitochondria Biogenesis in Rhabdomyosarcoma Cells Compared with 2,4-Dinitrophenol. Nutr Metab Insights. 2012;5:59–70.CrossRefPubMedPubMedCentral Vaughan RA, Garcia-smith R, Bisoffi M, Trujillo KA, Conn CA. Effects of Caffeine on Metabolism and Mitochondria Biogenesis in Rhabdomyosarcoma Cells Compared with 2,4-Dinitrophenol. Nutr Metab Insights. 2012;5:59–70.CrossRefPubMedPubMedCentral
34.
go back to reference Forrester M. Exposures to 1,3-dimethylamylamine-containing products reported to Texas poison centers. Hum Exp Toxicol. 2012;32:18–23.CrossRefPubMed Forrester M. Exposures to 1,3-dimethylamylamine-containing products reported to Texas poison centers. Hum Exp Toxicol. 2012;32:18–23.CrossRefPubMed
35.
go back to reference Smith TB, Staub B, Natarajan GM, Lasorda DM, Poornima IG. Acute Myocardial Infarction Associated with Dietary Supplements Containing 1,3-Dimethylamylamine and Citrus aurantium. Tex Heart Inst J. 2014;41:70–2.CrossRefPubMedPubMedCentral Smith TB, Staub B, Natarajan GM, Lasorda DM, Poornima IG. Acute Myocardial Infarction Associated with Dietary Supplements Containing 1,3-Dimethylamylamine and Citrus aurantium. Tex Heart Inst J. 2014;41:70–2.CrossRefPubMedPubMedCentral
36.
go back to reference Karnatovskaia LV, Leoni JC, Freeman ML. Cardiac Arrest in a 21-Year-Old Man After Ingestion of 1,3-DMAA – Containing Workout Supplement. Clin. J Sport Med. 2015;25:2014–6. Karnatovskaia LV, Leoni JC, Freeman ML. Cardiac Arrest in a 21-Year-Old Man After Ingestion of 1,3-DMAA – Containing Workout Supplement. Clin. J Sport Med. 2015;25:2014–6.
37.
go back to reference Gee P, Jackson S, Easton J. Another bitter pill: a case of toxicity from DMAA party pills. N Z Med J. 2010;123:124–7.PubMed Gee P, Jackson S, Easton J. Another bitter pill: a case of toxicity from DMAA party pills. N Z Med J. 2010;123:124–7.PubMed
38.
go back to reference Gee P, Tallon C, Long N, Moore G, Boet R, Jackson S. Use of recreational drug 1,3-dimethylethylamine (DMAA) associated with cerebral hemorrhage. Ann Emerg Med Elsevier Inc. 2012;60:431–4.CrossRef Gee P, Tallon C, Long N, Moore G, Boet R, Jackson S. Use of recreational drug 1,3-dimethylethylamine (DMAA) associated with cerebral hemorrhage. Ann Emerg Med Elsevier Inc. 2012;60:431–4.CrossRef
39.
go back to reference Young C, Oladipo O, Frasier S, Putko R, Chronister S, Marovich M. Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d. Mil Med. 2012;177:1450–4.CrossRefPubMed Young C, Oladipo O, Frasier S, Putko R, Chronister S, Marovich M. Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d. Mil Med. 2012;177:1450–4.CrossRefPubMed
40.
go back to reference Eliason MJ, Eichner A, Cancio A, Bestervelt L, Adams BD, Deuster PA. Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA). Mil Med. 2012;177:1455–9.CrossRefPubMed Eliason MJ, Eichner A, Cancio A, Bestervelt L, Adams BD, Deuster PA. Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA). Mil Med. 2012;177:1455–9.CrossRefPubMed
41.
go back to reference Holtzman SG, Finn IB. Tolerance to behavioral effects of caffeine in rats. Pharmacol Biochem Behav. 1988;29:411–8.CrossRefPubMed Holtzman SG, Finn IB. Tolerance to behavioral effects of caffeine in rats. Pharmacol Biochem Behav. 1988;29:411–8.CrossRefPubMed
Metadata
Title
Effects of controlled doses of Oxyelite Pro on physical performance in rats
Authors
Paulo Vinicios Camuzi Zovico
Victor Magalhães Curty
Marcos André Soares Leal
Eduardo Frizzera Meira
Daniel Ventura Dias
Lívia Carla de Melo Rodrigues
Silvana dos Santos Meyrelles
Edilamar Menezes De Oliveira
Paula Frizera Vassallo
Valério Garrone Barauna
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2016
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/s12986-016-0152-4

Other articles of this Issue 1/2016

Nutrition & Metabolism 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine